929 / 1498
Halasz et al
•
59 pts, 2001 – 2008, mFU 3.9y
•
All had PET (interim=50 &/or end=28) + RT
•
83% stage 1-2
•
98% RCHOP
•
22
pts had +ve PET
(7 iPET)
3y-LC
3y-PFS
Death
PET -ve
100%
97%
1 (2
nd
lymphoma)
PET +ve
90%
90%
1 (relapse)